21. Methylation of selenocysteine catalysed by thiopurine S-methyltransferaseDunja Urbančič, Anita Kotar, Alenka Šmid, Marko Jukič, Stanislav Gobec, Lars Martensson, Janez Plavec, Irena Mlinarič-Raščan, 2019, izvirni znanstveni članek Ključne besede: binding analysis, enzymatic methylation, NMR spectroscopy, S-adenosylmethionine, selenocysteine, thiopurine S-methyltransferase Celotno besedilo (datoteka, 1,48 MB) Gradivo ima več datotek! Več... |
22. The enhanced cytotoxic effects in B-cell leukemia and lymphoma following activation of prostaglandin EP4 receptor and targeting of CD20 antigen by monoclonal antibodiesTijana Markovič, Helena Podgornik, Damjan Avsec, Sanja Nabergoj, Irena Mlinarič-Raščan, 2022, izvirni znanstveni članek Ključne besede: B-cell leukemia and lymphoma, chronic lymphocytic leukemia, prostaglandin EP4 receptor, selective EP4 receptor agonist, monoclonal antibodies, synergistic effects Celotno besedilo (datoteka, 1,90 MB) Gradivo ima več datotek! Več... |
23. A comprehensive genetic analysis of Slovenian families with multiple cases of orofacial clefts reveals novel variants in the genes IRF6, GRHL3, and TBX22Lara Slavec, Ksenija Geršak, Andreja Eberlinc, Tinka Hovnik, Luca Lovrečić, Irena Mlinarič-Raščan, Nataša Karas Kuželički, 2023, izvirni znanstveni članek Ključne besede: genetics, family study, non-syndromic orofacial cleft, Van der Woude syndrome, X-linked cleft palate with or without ankyloglossia, IRF6, GRHL3, TBX22, whole exome sequencing Celotno besedilo (datoteka, 1,52 MB) Gradivo ima več datotek! Več... |
24. Polymorphisms in GNMT and DNMT3b are associated with methotrexate treatment outcome in plaque psoriasisJasna Grželj, Irena Mlinarič-Raščan, Pij B. Marko, Maruška Marovt, Tanja Gmeiner, Alenka Šmid, 2021, izvirni znanstveni članek Ključne besede: methotrexate, pharmacogenetics, psoriasis, methionine cycle, drug response, hepatotoxicity Celotno besedilo (datoteka, 2,77 MB) Gradivo ima več datotek! Več... |
25. EP4 receptor agonist L-902688 augments cytotoxic activities of ibrutinib, idelalisib, and venetoclax against chronic lymphocytic leukemia cellsSanja Nabergoj, Tijana Markovič, Damjan Avsec, Martina Gobec, Helena Podgornik, Žiga Jakopin, Irena Mlinarič-Raščan, 2021, izvirni znanstveni članek Ključne besede: chronic lymphocytic leukemia, L-902688, NF-κB inhibition, prostaglandin E4, receptor, synergistic cytotoxic activity, prostaglandin E4 receptor Celotno besedilo (datoteka, 3,50 MB) Gradivo ima več datotek! Več... |
|
|
|
|
|